Related Experiment Video

Updated: May 4, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K

Mutations in VPS26A are not a frequent cause of Parkinson's disease

Eva Koschmidder1, Brit Mollenhauer2, Meike Kasten3

  • 1Department of Neurogenetics, University of Lübeck, Lübeck, Germany.

Neurobiology of Aging
|January 15, 2014
PubMed

Insights

Mutations in VPS26A are not a common cause of Parkinson's disease (PD). Researchers screened patients and controls, finding variants unlikely to be disease-causing, suggesting other factors are more significant in PD development.

Area of Science:

  • Neurogenetics
  • Molecular Biology
  • Cell Biology

Background:

  • Mutations in VPS35 are linked to autosomal dominant Parkinson's disease (PD).
  • The retromer complex, including VPS35 and VPS26A, connects mitochondrial and lysosomal pathways, both implicated in PD pathogenesis.
  • Dysfunction in these pathways suggests a potential role for VPS26A in PD.

Purpose of the Study:

  • To investigate the association between VPS26A mutations and idiopathic Parkinson's disease (PD).
  • To screen for novel and known variants in the VPS26A gene in PD patients and control individuals.

Main Methods:

  • Genetic screening of the VPS26A gene in 245 idiopathic PD patients and 185 control subjects.
  • Identification and analysis of missense variants within the VPS26A gene.

Main Results:

  • Two novel missense variants in VPS26A were identified in PD patients.
  • Two known missense variants in VPS26A were found in control subjects.
  • The identified missense variants were determined to be unlikely to cause disease.

Conclusions:

  • VPS26A mutations do not appear to be a frequent cause of idiopathic Parkinson's disease.
  • Further research is needed to explore other genetic and molecular factors contributing to PD.
Keywords:
Parkinson's diseaseRetromer complexVPS26AVPS35

More Related Videos

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

11.6K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.2K

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K